These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 19889011
1. Kasabach-Merritt phenomenon: a single centre experience. Ryan C, Price V, John P, Mahant S, Baruchel S, Brandão L, Blanchette V, Pope E, Weinstein M. Eur J Haematol; 2010 Feb 01; 84(2):97-104. PubMed ID: 19889011 [Abstract] [Full Text] [Related]
2. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon. Fernandez-Pineda I, Lopez-Gutierrez JC, Chocarro G, Bernabeu-Wittel J, Ramirez-Villar GL. Pediatr Blood Cancer; 2013 Sep 01; 60(9):1478-81. PubMed ID: 23609996 [Abstract] [Full Text] [Related]
3. Treatment of Corticosteroid-Resistant Vascular Tumors Associated with the Kasabach-Merritt Phenomenon in Infants: An Approach with Transcatheter Arterial Embolization Plus Vincristine Therapy. Tan X, Chen M, Zhang J, Zhou S, Shen G, Liu Z, Jiang H, Xia J. J Vasc Interv Radiol; 2016 Apr 01; 27(4):569-75. PubMed ID: 26898623 [Abstract] [Full Text] [Related]
4. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S. Pediatr Blood Cancer; 2015 Apr 01; 62(4):577-80. PubMed ID: 25346262 [Abstract] [Full Text] [Related]
5. [Introduction of laparoscopic splenectomy for the treatment of immune thrombocytopenic purpura]. Kiudelis M, Endzinas Z, Mickevicius A, Reckauskas M. Zentralbl Chir; 2004 Apr 01; 129(2):108-13. PubMed ID: 15106041 [Abstract] [Full Text] [Related]
6. Outcome of Kasabach-Merritt phenomenon: the role of vincristine as monotherapy: report of a case. Traivaree C, Lumkul R, Torcharus K, Krutuecho T, Sriphaisal T. J Med Assoc Thai; 2012 May 01; 95 Suppl 5():S181-5. PubMed ID: 22934467 [Abstract] [Full Text] [Related]
7. Successful management of a small infant with Kasabach-Merritt phenomenon using vincristine: a case report. Economou M, Papagianni A, Tsigka A, Papouli M, Kattamis A, Gompakis N, Papachristou F. Blood Coagul Fibrinolysis; 2014 Oct 01; 25(7):777-9. PubMed ID: 24717422 [Abstract] [Full Text] [Related]
8. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. Haisley-Royster C, Enjolras O, Frieden IJ, Garzon M, Lee M, Oranje A, de Laat PC, Madern GC, Gonzalez F, Frangoul H, Le Moine P, Prose NS, Adams DM. J Pediatr Hematol Oncol; 2002 Oct 01; 24(6):459-62. PubMed ID: 12218593 [Abstract] [Full Text] [Related]
9. Kaposiform Haemangioendothelioma-spectrum Lesions with Kasabach-Merritt Phenomenon: Retrospective Analysis and Long-term Outcome. Boccara O, Fraitag S, Lasne D, Fontaine J, Bughin V, Hamel-Teillac D, Orbach D, Brunelle F, de Prost Y, Hadj-Rabia S, Bodemer C. Acta Derm Venereol; 2016 Jan 01; 96(1):77-81. PubMed ID: 26084625 [Abstract] [Full Text] [Related]
10. Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series. Baselga E, Cordisco MR, Garzon M, Lee MT, Alomar A, Blei F. Br J Dermatol; 2008 Jun 01; 158(6):1363-70. PubMed ID: 18410425 [Abstract] [Full Text] [Related]
11. [Clinical analysis of 17 cases of pneumatic compression therapy in infants with Kasabach-Merritt phenomenon]. Liu XJ, Tai MZ, Tian MX, Qin ZP. Zhonghua Yi Xue Za Zhi; 2009 Jul 14; 89(26):1830-3. PubMed ID: 19953927 [Abstract] [Full Text] [Related]
12. [Kasabach-Merritt syndrome on a congenital tufted angioma]. Enjolras O, Wassef M, Dosquet C, Drouet L, Fortier G, Josset P, Merland JJ, Escande JP. Ann Dermatol Venereol; 1998 Apr 14; 125(4):257-60. PubMed ID: 9747263 [Abstract] [Full Text] [Related]
13. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns. Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G. J Vasc Interv Radiol; 2012 Mar 14; 23(3):417-22. PubMed ID: 22365299 [Abstract] [Full Text] [Related]
14. Successful treatment of Kasabach-Merritt phenomenon with intralesional corticosteroid injections: a case series. Lee JJ, Lin LY, Hsieh SW, Chang TA, Jou ST, Liu CC, Chen MT. Ann Plast Surg; 2012 Dec 14; 69(6):627-32. PubMed ID: 23154333 [Abstract] [Full Text] [Related]
15. Deep venous thrombosis in children and adolescents. Levy ML, Granville RC, Hart D, Meltzer H. J Neurosurg; 2004 Aug 14; 101(1 Suppl):32-7. PubMed ID: 16206969 [Abstract] [Full Text] [Related]
16. Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline. de la Hunt MN. J Pediatr Surg; 2006 Jan 14; 41(1):e29-31. PubMed ID: 16410085 [Abstract] [Full Text] [Related]
17. Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: rethinking old cures. Shvidel L, Sigler E, Shtalrid M, Berrebi A. Am J Hematol; 2006 Jun 14; 81(6):423-5. PubMed ID: 16680744 [Abstract] [Full Text] [Related]
19. Vincristine for the treatment of Kasabach-Merritt syndrome: recent New Zealand case experience. Thomson K, Pinnock R, Teague L, Johnson R, Manikkam N, Drake R. N Z Med J; 2007 Feb 16; 120(1249):U2418. PubMed ID: 17308555 [Abstract] [Full Text] [Related]
20. [Comprehensive therapy for infant vascular tumor associated with Kasabach-Merritt phenomenon]. Miao X, Tianxiang O, Yan X, Yingying H, Huiping C, Jie Y, Xiaorong M, Tinghui Z, Mengling C, Jun L, Jun L. Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul 16; 31(4):263-8. PubMed ID: 26665925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]